Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series

Background Post-Covid syndrome (PCS) has been an ongoing challenge since the COVID-19 pandemic. Relatively little is known about the effect of whole-body hyperthermia (WBH) in the treatment of PCS.Methods We retrospectively analyzed the data of patients with PCS who were treated as inpatients with a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Vagedes, Thomas Breitkreuz, Victoria Heinrich, Mohsen Sobh, Mohammad Oli Al Islam, Katrin Vagedes, Jan Mergelsberg
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2025.2488792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187255589634048
author Jan Vagedes
Thomas Breitkreuz
Victoria Heinrich
Mohsen Sobh
Mohammad Oli Al Islam
Katrin Vagedes
Jan Mergelsberg
author_facet Jan Vagedes
Thomas Breitkreuz
Victoria Heinrich
Mohsen Sobh
Mohammad Oli Al Islam
Katrin Vagedes
Jan Mergelsberg
author_sort Jan Vagedes
collection DOAJ
description Background Post-Covid syndrome (PCS) has been an ongoing challenge since the COVID-19 pandemic. Relatively little is known about the effect of whole-body hyperthermia (WBH) in the treatment of PCS.Methods We retrospectively analyzed the data of patients with PCS who were treated as inpatients with a multimodal integrative therapy approach including WBH. The primary outcome comprised changes in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) between T0 (at hospital admission) and T2 (four weeks after discharge), secondary outcomes were changes in Fatigue Impact Scale (FIS-D), Multidimensional Dyspnea Profile (MDP) and Covid-Associated Symptoms (CAS) between T0–T1 (at discharge) and T0–T2.Results FACIT-F yielded a significant increase (p < 0.001) between T0 (19.1 ± 8.4) and T2 (29.9 ± 13.0) (primary outcome), indicating an improved health status. While FIS-D and CAS scores improved significantly between T0 and T2, dyspnea parameters improved only between T0 and T1. 63% of respondents identified WBH as an effective treatment.Conclusions Study results provide preliminary evidence for potentially positive effects of WBH in the setting of this study, in which it is embedded in a multimodal therapy approach. The results should be substantiated by future RCTs to identify specific effects of individual therapy components.
format Article
id doaj-art-1ed8b64b09444f34a41ca80e62648381
institution OA Journals
issn 0265-6736
1464-5157
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj-art-1ed8b64b09444f34a41ca80e626483812025-08-20T02:16:09ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572025-12-0142110.1080/02656736.2025.2488792Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case seriesJan Vagedes0Thomas Breitkreuz1Victoria Heinrich2Mohsen Sobh3Mohammad Oli Al Islam4Katrin Vagedes5Jan Mergelsberg6ARCIM Institute (Academic Research in Complementary and Integrative Medicine), Filderstadt, GermanyParacelsus Krankenhaus Unterlengenhardt, Bad Liebenzell, GermanyParacelsus Krankenhaus Unterlengenhardt, Bad Liebenzell, GermanyARCIM Institute (Academic Research in Complementary and Integrative Medicine), Filderstadt, GermanyARCIM Institute (Academic Research in Complementary and Integrative Medicine), Filderstadt, GermanyARCIM Institute (Academic Research in Complementary and Integrative Medicine), Filderstadt, GermanyParacelsus Krankenhaus Unterlengenhardt, Bad Liebenzell, GermanyBackground Post-Covid syndrome (PCS) has been an ongoing challenge since the COVID-19 pandemic. Relatively little is known about the effect of whole-body hyperthermia (WBH) in the treatment of PCS.Methods We retrospectively analyzed the data of patients with PCS who were treated as inpatients with a multimodal integrative therapy approach including WBH. The primary outcome comprised changes in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) between T0 (at hospital admission) and T2 (four weeks after discharge), secondary outcomes were changes in Fatigue Impact Scale (FIS-D), Multidimensional Dyspnea Profile (MDP) and Covid-Associated Symptoms (CAS) between T0–T1 (at discharge) and T0–T2.Results FACIT-F yielded a significant increase (p < 0.001) between T0 (19.1 ± 8.4) and T2 (29.9 ± 13.0) (primary outcome), indicating an improved health status. While FIS-D and CAS scores improved significantly between T0 and T2, dyspnea parameters improved only between T0 and T1. 63% of respondents identified WBH as an effective treatment.Conclusions Study results provide preliminary evidence for potentially positive effects of WBH in the setting of this study, in which it is embedded in a multimodal therapy approach. The results should be substantiated by future RCTs to identify specific effects of individual therapy components.https://www.tandfonline.com/doi/10.1080/02656736.2025.2488792Post-Covid syndromewhole-body hyperthermiaintegrative medicineanthroposophic medicinefatiguemulti-modal integrative therapy
spellingShingle Jan Vagedes
Thomas Breitkreuz
Victoria Heinrich
Mohsen Sobh
Mohammad Oli Al Islam
Katrin Vagedes
Jan Mergelsberg
Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
International Journal of Hyperthermia
Post-Covid syndrome
whole-body hyperthermia
integrative medicine
anthroposophic medicine
fatigue
multi-modal integrative therapy
title Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
title_full Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
title_fullStr Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
title_full_unstemmed Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
title_short Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome – a case series
title_sort whole body hyperthermia as part of a multimodal treatment for patients with post covid syndrome a case series
topic Post-Covid syndrome
whole-body hyperthermia
integrative medicine
anthroposophic medicine
fatigue
multi-modal integrative therapy
url https://www.tandfonline.com/doi/10.1080/02656736.2025.2488792
work_keys_str_mv AT janvagedes wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT thomasbreitkreuz wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT victoriaheinrich wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT mohsensobh wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT mohammadolialislam wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT katrinvagedes wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries
AT janmergelsberg wholebodyhyperthermiaaspartofamultimodaltreatmentforpatientswithpostcovidsyndromeacaseseries